Sarah Murless-Collins,Kondwani Kawaza,Nahya Salim,Elizabeth M Molyneux,Msandeni Chiume,Jalemba Aluvaala,William M Macharia,Veronica Chinyere Ezeaka,Opeyemi Odedere,Donat Shamba,Robert Tillya,Rebecca E Penzias,Beatrice Nkolika Ezenwa,Eric O Ohuma,James H Cross,Joy E Lawn,NEST360 Infection Group,Helen Bokea,Christine Bohne,Mary Waiyego,Grace Irimu,Ifeanyichukwu Anthony Ogueji,Georgia Jenkins,Olukemi O Tongo,Iretiola Fajolu,Nike Olutekunbi,Cate Paul,Jitihada Baraka,Rebecca Kirby,Kara Palamountain

Abstract:Background: Thirty million small and sick newborns worldwide require inpatient care each year. Many receive antibiotics for clinically diagnosed infections without blood cultures, the current 'gold standard' for neonatal infection detection. Low neonatal blood culture use hampers appropriate antibiotic use, fuelling antimicrobial resistance (AMR) which threatens newborn survival. This study analysed the gap between blood culture use and antibiotic prescribing in hospitals implementing with Newborn Essential Solutions and Technologies (NEST360) in Kenya, Malawi, Nigeria, and Tanzania. Methods: Inpatient data from every newborn admission record (July 2019-August 2022) were included to describe hospital-level blood culture use and antibiotic prescription. Health Facility Assessment data informed performance categorisation of hospitals into four tiers: (Tier 1) no laboratory, (Tier 2) laboratory but no microbiology, (Tier 3) neonatal blood culture use < 50% of newborns receiving antibiotics, and (Tier 4) neonatal blood culture use > 50%. Results: A total of 144,146 newborn records from 61 hospitals were analysed. Mean hospital antibiotic prescription was 70% (range = 25-100%), with 6% mean blood culture use (range = 0-56%). Of the 10,575 blood cultures performed, only 24% (95%CI 23-25) had results, with 10% (10-11) positivity. Overall, 40% (24/61) of hospitals performed no blood cultures for newborns. No hospitals were categorised as Tier 1 because all had laboratories. Of Tier 2 hospitals, 87% (20/23) were District hospitals. Most hospitals could do blood cultures (38/61), yet the majority were categorised as Tier 3 (36/61). Only two hospitals performed > 50% blood cultures for newborns on antibiotics (Tier 4). Conclusions: The two Tier 4 hospitals, with higher use of blood cultures for newborns, underline potential for higher blood culture coverage in other similar hospitals. Understanding why these hospitals are positive outliers requires more research into local barriers and enablers to performing blood cultures. Tier 3 facilities are missing opportunities for infection detection, and quality improvement strategies in neonatal units could increase coverage rapidly. Tier 2 facilities could close coverage gaps, but further laboratory strengthening is required. Closing this culture gap is doable and a priority for advancing locally-driven antibiotic stewardship programmes, preventing AMR, and reducing infection-related newborn deaths.

Publication Recommendations to Report Laboratory Data of Neonates – a Modified Delphi Approach

Analysis of the characteristics and management of critical values in a newborn tertiary center in China

Safety, dosing, and pharmaceutical quality for studies that evaluate medicinal products (including biological products) in neonates

Interdisciplinary Collaboration on Real World Data to Close the Knowledge Gap: A Reflection on "De Sutter et al. Predicting Volume of Distribution in Neonates: Performance of Physiologically Based Pharmacokinetic Modelling"

Kidney Health Monitoring in Neonatal Intensive Care Unit Graduates: A Modified Delphi Consensus Statement

Essential variables for reporting research studies on fetal growth restriction: a Delphi consensus

Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data

Estimation of gestational age-specific reference intervals for coagulation assays in a neonatal intensive care unit using real-world data

Bioinformatics in Neonatal/Pediatric Medicine—A Literature Review

Adverse drug reactions in neonates: a brief analysis of the FDA adverse event reporting system

Analysis of serum FT4 concentrations in healthy term neonates underlines need for local and laboratory-specific reference interval: a systematic review and meta-analysis of individual participant data

Fetal and neonatal post-mortem imaging referral template: recommendations from the European Society of Paediatric Radiology Post-mortem Task Force

Recommendations for data collection in cohort studies of preterm born individuals – The RECAP Preterm Core Dataset

Standardised and structured reporting in fetal magnetic resonance imaging: recommendations from the Fetal Task Force of the European Society of Paediatric Radiology

Publishing Without Perishing: A Guide to the Successful Reporting of Clinical Data

Methods applied to neonatal dried blood spot samples for secondary research purposes: a scoping review

Considerations for applying emerging technologies in paediatric laboratory medicine

Blood culture versus antibiotic use for neonatal inpatients in 61 hospitals implementing with the NEST360 Alliance in Kenya, Malawi, Nigeria, and Tanzania: a cross-sectional study

Fetal laboratory medicine: on the frontier of maternal-fetal medicine

Data Quality Improvement and Internal Data Audit of the Chinese Neonatal Network Data Collection System

Growth charts for use at birth and in the neonatal period: Recommendations of the French Neonatal Society